Abstract:BackgroundAgitation is very common in patients with acute stage schizophrenia, and injection of antipsychotics and clonazepam is widely used. Network meta-analysis of these comparisons among three injection treatments has been seldom reported.AimTo compare the efficacy and safety of various injections for agitation symptoms in Chinese patients with schizophrenia.MethodsSearches were made in PubMed, Embase and Web of Knowledge, Cochrane Library, Wanfang data, CNKI, SinoMed and VIP databases up to 18 February 2018. Standard search strategies were performed by two reviewers according to the Cochrane Review Group. The Consolidated Standards of Reporting Trials statement was used to assess the methodological quality of the studies. STATA was used to perform meta-analysis. The Cochrane Grades of Recommendation, Assessment, Development and Evaluation (GRADE) was used to assess the strength of evidence.ResultsA total of 15 studies were included in the network meta-analysis. There were 11 studies comparing ziprasidone with haloperidol, and four studies comparing haloperidol with clonazepam. The results showed that ziprasidone is more effective than haloperidol and clonazepam (sucra: 77.2, 72.8 and 0) in the treatment of agitation symptoms. There was the effect size (standardised mean difference (SMD)) in the three groups: haloperidol: SMD=2.278, 95% CI 1.836 to 2.719; ziprasidone: SMD=2.536, 95% CI 2.082 to 2.990; and clonazepam: SMD=1.360, 95% CI 0.127 to 2.593. The acceptability was assessed by the incidence of excessive sedation, which showed that ziprasidone and haloperidol were similar with both being superior to clonazepam (sucra: 0.3, 0.7 and 99.0). Ziprasidone had significantly less adverse effects than haloperidol in effects of extrapyramidal system (EPS) (z=5.01, p<0.001). There were no statistically significant differences between haloperidol and ziprasidone in tachycardia and abnormal ECG (z=1.69, p=0.091; z=0.87, p=0.386; respectively). Based on GRADE, the strength of the evidence for primary outcome was ‘medium’.ConclusionOur results suggested that ziprasidone was more suitable than haloperidol and clonazepam in the treatment of agitation symptoms in Chinese patients with schizophrenia, according to the efficacy and acceptability of these three intramuscular injection medications.

A Multicenter, Randomized, and Double-Blind Controlled Clinical Trial of Lorazepam Injection Vs Diazepam Injection in Treatment of Anxiety State

Randomized,multicenter,double blind comparative trial of reboxetine in the treatment of depression with or without anxiety

A double blinded multicenter clinical trial for evaluating the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia

A comparison study of sertraline,venlafxin and alprazolam in treatment of generalized anxiety disorder

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Efficacy and Safety of Ethyl Loflazepate(21 Patients) Vs Diazepam(22 Patients) in Treatment of Anxiety Disorders

Comparison of ethyl loflazepate (79 patients) with diazepam (75 patients) in treatment of anxiety disorders:a randomized,multicenter,double-blind study

Efficacy and safety of ethy1 loflazepate(34 patients) vs diazepam(32 patients) in treatment of anxiety disorders

Double-blind,double-dummy and randomized controlled study of aripiprazole in the treatment of acute schizophrenia

Ziprasidone, Haloperidol and Clonazepam Intramuscular Administration in the Treatment of Agitation Symptoms in Chinese Patients with Schizophrenia: A Network Meta-Analysis

The evidence-based formulation of the administration standards for diazepam injection

A Randomized, Double-Blind, Double-Dummy, Multicenter, Controlled Trial on Brotizolam Intervention in Outpatients with Insomnia

A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study

Efficacy and safety of Jiuwei Zhenxin Keli in treatment of generalized anxiety disorder:A multi-center randomized double-blind controlled trial

Multi-center, randomized, blinded, parallel control clinical study of cefazedone injection and cefazolin injection in the treatment of acute bacterial respiratory infections

A multicenter,randomized,double-blind,controlled clinical trial of domestic zaleplon for insomnia

Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature

Randomized controlled trial of acupuncture for anxiety and depression in patients with chronic insomnia

Efficacy and safety of auricular acupressure on reduction of estazolam in patients with insomnia: a study protocol for a three-arm, blinded randomized controlled trial

Intranasal Dexmedetomidine for the Treatment of Pre-operative Anxiety and Insomnia: A Prospective, Randomized, Controlled, and Clinical Trial

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial